Hybrid 2-Aminotetralin and Aryl-Substituted Piperazine Compounds and their Use in Altering CNS Activity
申请人:Dutta Aloke K.
公开号:US20100210663A1
公开(公告)日:2010-08-19
Hybrid compounds containing an aminotetralin moiety or a heterocyclic and/or open chain analog thereof linked through an alkylene group to an aryl ring system-substituted piperidiene moiety exhibit high levels of CNS activity, in some cases exhibiting especially high relative binding efficiencies between D3 and D2 dopaminergic receptor subtypes.
含有氨基四氢萘基团或其杂环和/或开链类似物的杂化化合物,通过烷基链连接到芳环系统取代的哌啶基团,表现出高水平的中枢神经系统活性,在某些情况下,表现出特别高的D3和D2多巴胺受体亚型之间相对结合效率。